Risk Factors for Invasive Aspergillosis in Patients Admitted to the Intensive Care Unit With Coronavirus Disease 2019: A Multicenter Retrospective Study

Risk Factors for Invasive Aspergillosis in Patients Admitted to the Intensive Care Unit With Coronavirus Disease 2019: A Multicenter Retrospective Study

Background: Invasive pulmonary aspergillosis (IPA) is a life-threatening complication in coronavirus disease 2019 (COVID-19) patients admitted to intensive care units (ICUs), but risk factors for COVID-19-associated IPA (CAPA) have not been fully characterized. The aim of the current study was to id...

Full description

Bibliographic Details
Main Authors:	Jiqian Xu, Xiaobo Yang, Zheng Lv, Ting Zhou, Hong Liu, Xiaojing Zou, Fengsheng Cao, Lu Zhang, Boyi Liu, Wei Chen, Yuan Yu, Huaqing Shu, Shiying Yuan, Ming Hu, Chaolin Huang, You Shang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-11-01
Series:	Frontiers in Medicine
Subjects:	COVID-19 CAPA methylprednisolone mortality thrombocytopenia
Online Access:	https://www.frontiersin.org/articles/10.3389/fmed.2021.753659/full

Similar Items

A Novel Risk-Stratification Models of the High-Flow Nasal Cannula Therapy in COVID-19 Patients With Hypoxemic Respiratory Failure
by: Jiqian Xu, et al.
Published: (2020-12-01)

Narrative Review of Neurologic Complications in Adults on ECMO: Prevalence, Risks, Outcomes, and Prevention Strategies
by: Hongling Zhang, et al.
Published: (2021-09-01)

Invasive Pulmonary Aspergillosis in Patients with and without SARS-CoV-2 Infection
by: Jesús Fortún, et al.
Published: (2023-01-01)

Long-term sedation with remimazolam besylate versus propofol in critically ill patients during invasive mechanical ventilation: a study protocol for a multicenter randomized non-inferior trial
by: Xiaobo Yang, et al.
Published: (2023-07-01)

Clinical course and predictors of 60-day mortality in 239 critically ill patients with COVID-19: a multicenter retrospective study from Wuhan, China
by: Jiqian Xu, et al.
Published: (2020-07-01)

Remimazolam besylate for sedation of postoperative patients in intensive care units: a phase I, open label, dose-finding study
by: Yun Tang, et al.
Published: (2022-09-01)

Bioinformatic analysis identifies potential biomarkers and therapeutic targets of septic-shock-associated acute kidney injury
by: Yun Tang, et al.
Published: (2021-04-01)

Prone positioning in ARDS patients supported with VV ECMO, what we should explore?
by: Hongling Zhang, et al.
Published: (2022-10-01)

Methylprednisolone versus intravenous immune globulin as an initial therapy in adult primary immune thrombocytopenia
by: Chul Hee Kim, et al.
Published: (2019-03-01)

Clinical characteristics and risk factors associated with ICU-acquired infections in sepsis: A retrospective cohort study
by: Yajun He, et al.
Published: (2022-07-01)

Unusual manifestation of COVID‐19‐associated pulmonary aspergillosis: A case report
by: Maryam Albaji, et al.
Published: (2022-08-01)

COVID-19-Associated Pulmonary Aspergillosis in a Tertiary Hospital
by: García-Clemente Marta, et al.
Published: (2022-01-01)

Integrative proteomic profiling of lung tissues and blood in acute respiratory distress syndrome
by: Rui Gong, et al.
Published: (2023-05-01)

Nanomaterials targeting macrophages in sepsis: A promising approach for sepsis management
by: Chaoying Song, et al.
Published: (2022-12-01)

The Abnormal Imaging of SARS-CoV-2: A Predictive Measure of Disease Severity
by: Shangwen Pan, et al.
Published: (2021-10-01)

COVID-19 Associated Pulmonary Aspergillosis (CAPA): Hospital or Home Environment as a Source of Life-Threatening <i>Aspergillus fumigatus</i> Infection?
by: Teresa Peláez-García de la Rasilla, et al.
Published: (2022-03-01)

Negative regulator NLRC3: Its potential role and regulatory mechanism in immune response and immune-related diseases
by: Deyi Sun, et al.
Published: (2022-10-01)

Pulmonary Aspergillosis in Critically Ill COVID-19 Patients Admitted to the Intensive Care Unit: A Retrospective Cohort Study
by: Felix Bergmann, et al.
Published: (2023-03-01)

Diagnosis and Antifungal Prophylaxis for COVID-19 Associated Pulmonary Aspergillosis
by: Armani M. Hawes, et al.
Published: (2022-11-01)

COVID-19 associated mold infections: Review of COVID-19 associated pulmonary aspergillosis and mucormycosis
by: Shiang-Fen Huang, et al.
Published: (2023-06-01)

Gut Microbial Disruption in Critically Ill Patients with COVID-19-Associated Pulmonary Aspergillosis
by: H. Carlo Maurer, et al.
Published: (2022-11-01)

Cytokine Profile of Invasive Pulmonary Aspergillosis in Severe COVID-19 and Possible Therapeutic Targets
by: Alessandro Russo, et al.
Published: (2022-06-01)

COVID-19-associated pulmonary aspergillosis in intensive care unit: A real-life experience
by: Alessandro Russo, et al.
Published: (2024-01-01)

Novel Clinical and Laboratorial Challenges in Aspergillosis
by: Raquel Sabino, et al.
Published: (2022-01-01)

Invasive Pulmonary Aspergillosis: Not Only a Disease Affecting Immunosuppressed Patients
by: Rafael Zaragoza, et al.
Published: (2023-01-01)

Tracheal Aspirate Galactomannan Testing in COVID-19-Associated Pulmonary Aspergillosis
by: Carla M. Román-Montes, et al.
Published: (2022-04-01)

Influenza- and COVID-19-Associated Pulmonary Aspergillosis: Are the Pictures Different?
by: Florian Reizine, et al.
Published: (2021-05-01)

Diagnostic performance and longitudinal analysis of fungal biomarkers in COVID-19 associated pulmonary aspergillosis
by: Berrin Er, et al.
Published: (2023-11-01)

Regional Impact of COVID-19-Associated Pulmonary Aspergillosis (CAPA) during the First Wave
by: Robbert G. Bentvelsen, et al.
Published: (2022-01-01)

Corticosteroids as risk factor for COVID-19-associated pulmonary aspergillosis in intensive care patients
by: Rasmus Leistner, et al.
Published: (2022-01-01)

Pulmonary aspergillosis and cryptococcosis as a complication of COVID-19
by: Edward C. Traver, et al.
Published: (2022-03-01)

COVID-19-Associated Pulmonary Aspergillosis: A Single-Center Experience in Central Valley, California, January 2020–March 2021
by: Geetha Sivasubramanian, et al.
Published: (2021-11-01)

Capa e Dados Técnicos
by: Andre Rezende Benatti
Published: (2021-11-01)

capa
by: os editores
Published: (2015-06-01)

Remimazolam besylate versus propofol for long-term sedation during invasive mechanical ventilation: a pilot study
by: Yun Tang, et al.
Published: (2022-09-01)

The Effect of a Combined Ganciclovir, Methylprednisolone, and Immunoglobulin Regimen on Survival and Functional Outcomes in Patients With Japanese Encephalitis
by: Wang Miao, et al.
Published: (2021-11-01)

A Clinical Case of COVID-19-Associated Pulmonary Aspergillosis (CAPA), Illustrating the Challenges in Diagnosis (Despite Overwhelming Mycological Evidence)
by: P. Lewis White, et al.
Published: (2022-01-01)

COVID-19-associated pulmonary aspergillosis is associated with increased in-hospital mortality and prolonged SARS-CoV-2 viral shedding
by: Jhong-Ru Huang, et al.
Published: (2022-12-01)

COVID-19 associated pulmonary aspergillosis (CAPA): An Australian case report
by: Avinash Sharma, et al.
Published: (2021-03-01)

Invasive pulmonary aspergillosis in COVID-19 patients
by: V. G. Gusarov, et al.
Published: (2021-03-01)